Chinese General Practice ›› 2023, Vol. 26 ›› Issue (36): 4587-4594.DOI: 10.12114/j.issn.1007-9572.2023.0339
Special Issue: 肿瘤最新文章合集
• Article • Previous Articles Next Articles
Received:
2023-04-09
Revised:
2023-07-12
Published:
2023-12-20
Online:
2023-07-21
Contact:
ZHOU Shangcheng
通讯作者:
周尚成
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0339
Figure 2 Changes in standardized mortality rate,DALYs rate,YLDs rate,and YLDs rate for esophageal cancer attributable to tobacco in China from 1990 to 2019
分类 | 时间(年) | APC(%) | 95%CI(%) | P值 | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|---|---|---|---|
总人群 | 1990—1998 | -0.1 | (-0.4,0.1) | 0.027 | -1.4 | (-1.6,-1.2) | <0.001 |
总人群 | 1998—2004 | 1.8 | (1.3,2.3) | <0.001 | |||
总人群 | 2004—2014 | -4.4 | (-4.6,-4.3) | <0.001 | |||
总人群 | 2014—2017 | -2.2 | (-3.7,-0.7) | 0.007 | |||
总人群 | 2017—2019 | 0.5 | (1.3,2.3) | 0.055 | |||
女性 | 1990—1993 | 3.7 | (2.6,4.8) | <0.001 | -3.3 | (-3.6,-2.9) | <0.001 |
女性 | 1993—1998 | -0.2 | (-0.9,0.5) | 0.052 | |||
女性 | 1998—2001 | 1.4 | (-0.8,3.8) | 0.019 | |||
女性 | 2001—2004 | -1.1 | (-3.4,1.3) | 0.034 | |||
女性 | 2004—2015 | -8.3 | (-8.5,-8.2) | <0.001 | |||
女性 | 2015—2019 | -2.7 | (-3.3,-2.1) | <0.001 | |||
男性 | 1990—1997 | -0.6 | (-0.9,-0.3) | <0.001 | -1.3 | (-1.4,-1.1) | <0.001 |
男性 | 1997—2004 | 1.7 | (1.3,2.1) | <0.001 | |||
男性 | 2004—2015 | -3.8 | (-3.9,-3.6) | <0.001 | |||
男性 | 2015—2019 | -0.6 | (-1.2,-0.1) | 0.026 |
Table 1 Trends in esophageal cancer mortality attributable to tobacco in China from 1990 to 2019
分类 | 时间(年) | APC(%) | 95%CI(%) | P值 | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|---|---|---|---|
总人群 | 1990—1998 | -0.1 | (-0.4,0.1) | 0.027 | -1.4 | (-1.6,-1.2) | <0.001 |
总人群 | 1998—2004 | 1.8 | (1.3,2.3) | <0.001 | |||
总人群 | 2004—2014 | -4.4 | (-4.6,-4.3) | <0.001 | |||
总人群 | 2014—2017 | -2.2 | (-3.7,-0.7) | 0.007 | |||
总人群 | 2017—2019 | 0.5 | (1.3,2.3) | 0.055 | |||
女性 | 1990—1993 | 3.7 | (2.6,4.8) | <0.001 | -3.3 | (-3.6,-2.9) | <0.001 |
女性 | 1993—1998 | -0.2 | (-0.9,0.5) | 0.052 | |||
女性 | 1998—2001 | 1.4 | (-0.8,3.8) | 0.019 | |||
女性 | 2001—2004 | -1.1 | (-3.4,1.3) | 0.034 | |||
女性 | 2004—2015 | -8.3 | (-8.5,-8.2) | <0.001 | |||
女性 | 2015—2019 | -2.7 | (-3.3,-2.1) | <0.001 | |||
男性 | 1990—1997 | -0.6 | (-0.9,-0.3) | <0.001 | -1.3 | (-1.4,-1.1) | <0.001 |
男性 | 1997—2004 | 1.7 | (1.3,2.1) | <0.001 | |||
男性 | 2004—2015 | -3.8 | (-3.9,-3.6) | <0.001 | |||
男性 | 2015—2019 | -0.6 | (-1.2,-0.1) | 0.026 |
年龄(岁) | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|
30~34 | -1.7 | (-2.6,-0.8) | <0.001 |
>34~39 | -2.2 | (-2.6,-1.8) | <0.001 |
>39~44 | -3.0 | (-3.3,-2.8) | <0.001 |
>44~49 | -2.7 | (-3.2,-2.2) | <0.001 |
>49~54 | -2.4 | (-2.7,-2.1) | <0.001 |
>54~59 | -2.3 | (-2.7,-1.9) | <0.001 |
>59~64 | -1.8 | (-2,-1.6) | <0.001 |
>64~69 | -1.8 | (-2.1,-1.4) | <0.001 |
>69~74 | -1.3 | (-1.6,-1.1) | <0.001 |
>74~79 | -1.0 | (-1.4,-0.6) | <0.001 |
>79~84 | -0.5 | (-0.8,-0.1) | 0.007 |
>84~89 | 0.2 | (0,0.5) | 0.042 |
>89~94 | -0.6 | (-0.9,-0.2) | 0.001 |
≥95 | -1.7 | (-2,-1.3) | <0.001 |
Table 2 Trends in age-specific mortality rates for esophageal cancer attributable to tobacco in China from 1990 to 2019
年龄(岁) | AAPC(%) | 95%CI(%) | P值 |
---|---|---|---|
30~34 | -1.7 | (-2.6,-0.8) | <0.001 |
>34~39 | -2.2 | (-2.6,-1.8) | <0.001 |
>39~44 | -3.0 | (-3.3,-2.8) | <0.001 |
>44~49 | -2.7 | (-3.2,-2.2) | <0.001 |
>49~54 | -2.4 | (-2.7,-2.1) | <0.001 |
>54~59 | -2.3 | (-2.7,-1.9) | <0.001 |
>59~64 | -1.8 | (-2,-1.6) | <0.001 |
>64~69 | -1.8 | (-2.1,-1.4) | <0.001 |
>69~74 | -1.3 | (-1.6,-1.1) | <0.001 |
>74~79 | -1.0 | (-1.4,-0.6) | <0.001 |
>79~84 | -0.5 | (-0.8,-0.1) | 0.007 |
>84~89 | 0.2 | (0,0.5) | 0.042 |
>89~94 | -0.6 | (-0.9,-0.2) | 0.001 |
≥95 | -1.7 | (-2,-1.3) | <0.001 |
[1] |
|
[2] |
|
[3] |
Global Burden of Disease Cancer Collaboration,
|
[4] |
GBD 2017 Oesophageal Cancer Collaborators. The global,regional,and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories,1990-2017:a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Gastroenterol Hepatol,2020,5(6):582-597. DOI:10.1016/S2468-1253(20)30007-8.
|
[5] |
GBD Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and teRRitories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1223-1249. DOI:10.1016/S0140-6736(20)30752-2.
|
[6] |
GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories,1990-2019:a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020,396(10258):1204-1222. DOI:10.1016/S0140-6736(20)30925-9.
|
[7] |
|
[8] |
曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用[J]. 中国卫生统计,2019,36(5):787-791.
|
[9] |
曾四清,李艳,刘珺,等. 两组序列数据趋势变化特征对比分析的Joinpoint回归模型方法及应用[J]. 中国卫生统计,2021,38(2):307-311. DOI:10.3969/j.issn.1002-3674.2021.02.039.
|
[10] |
李辉章,杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J]. 中华预防医学杂志,2020,54(8):908-912. DOI:10.3760/cma.j.cn112150-20200616-00889.
|
[11] |
|
[12] |
|
[13] |
梁珊珊,周智华,李成程,等. 1990—2019年中国糖尿病疾病负担及发病预测分析[J]. 中国全科医学,2023,26(16):2013-2019. DOI:10.12114/j.issn.1007-9572.2023.0009.
|
[14] |
许晴晴,严永富,陈浩,等. 中国四大慢性病死亡率可持续发展目标实现的预测研究[J]. 中华流行病学杂志,2022,43(6):878-884. DOI:10.3760/cma.j.cn112338-20211028-00830.
|
[15] |
陈飞,王悠清. 1990—2019年中国食管癌疾病负担及其变化趋势分析[J]. 中国肿瘤,2021,30(6):401-407. DOI:10.11735/j.issn.1004-0242.2021.06.A001.
|
[16] | |
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
健康中国行动(2019—2030年)[EB/OL].(2019-07-15)[2023-03-02].
|
[1] | ZHU Wenpeng, HAN Mengqi, WANG Yuxin, WANG Guoping. Trends and Projections of Incidence and Mortality of Nasopharyngeal Carcinoma in China from 1990 to 2019 [J]. Chinese General Practice, 2023, 26(34): 4269-4276. |
[2] | MA Liyuan, WANG Zengwu, FAN Jing, HU Shengshou. Interpretation of Report on Cardiovascular Health and Diseases in China 2022 [J]. Chinese General Practice, 2023, 26(32): 3975-3994. |
[3] | ZHANG Jifang, CHEN Fang, TANG Jiawen, LI Hongliang. Predictive Value of Tumor Budding and Tumor-infiltrating Lymphocytes on Lymph Node Metastasis of Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(32): 4038-4042. |
[4] | ZHANG Ming, XU Jing, SUN Zhenhua, ZHAO Wenhao, MA Yingqian, ZHANG Jianqiao, SHEN Haiping. Improvement of Nutritional Status of Elderly Patients with Severe Obstruction Esophageal Carcinoma by Image-guided Photodynamic Therapy [J]. Chinese General Practice, 2023, 26(30): 3780-3784. |
[5] | LI Jilei, LI Honglin, XU Yanchao, LIU Yanan, CHEN Mengli, SHAO Shuai, MA Chunzheng. Clinical Study on the Combination of Xiaotan Huayu Tongyi Granules, Channel Kaijie Pills and Chemotherapy in the Treatment of Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3759-3764. |
[6] | ZHENG Yuling, ZHANG Yaling, LIU Huaimin, XU Yanchao, JIA Xiaolin, LI Junsai, HE Wenlong, TONG Xinduo, QIN Shanwen, ZHANG Lihan. Clinical Observation of Dingxiang Guanshitong Hanhua Pills Alone and Its Combination with Fugui Guanshitong Granules in the Treatment of Advanced Esophageal Cancer [J]. Chinese General Practice, 2023, 26(30): 3765-3771. |
[7] | MA Yanyan, REN Fuxian, WANG Yu, GAO Dengfeng. The Prediction Value of (Neutrophil+Monocyte) /Lymphocyte Ratio on In-hospital Mortality of Heart Failure Patients [J]. Chinese General Practice, 2023, 26(30): 3791-3796. |
[8] | XU Zhe, ZHANG Jinxia, ZHANG Xiuhong, XIE Kaihong. Relationship between Sleep Duration and All-cause Mortality in Middle-aged and Older Adults [J]. Chinese General Practice, 2023, 26(28): 3507-3512. |
[9] | XUE Shan, LI Laiyou, LIANG Junli, JIN Yinghui, WEI Shuyan. The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(20): 2540-2547. |
[10] | ZHANG Yushuang, KONG Lingyang, GUAN Jiachang, LI Jianbo, WANG Yiran, WANG Yu, LI Jing. 16S rDNA Sequence Analysis of the Characteristics of Gut Flora in Patients with Esophageal Squamous Cell Carcinoma [J]. Chinese General Practice, 2023, 26(20): 2496-2502. |
[11] | SUN Xuhai, SHI Xiuxiu, ZHAO Zhengzheng, HAN Jinxiang. Characteristics of Newly Increased and Deceased Patients with Severe Mental Illness in a Community in Beijing from 2011 to 2021 [J]. Chinese General Practice, 2023, 26(19): 2402-2407. |
[12] | ZHAI Leilei, ZHAO Shupeng, YAO Ping. Meta-analysis of the Relationship between Dietary Inflammatory Index and Upper Gastrointestinal Cancer Risks [J]. Chinese General Practice, 2023, 26(18): 2286-2292. |
[13] | LIANG Shanshan, ZHOU Zhihua, LI Chengcheng, CHEN Huijing, ZHOU Shangcheng. Diabetes in China: Burden Analysis between 1990 and 2019 and Incidence Prediction between 2020 and 2030 [J]. Chinese General Practice, 2023, 26(16): 2013-2019. |
[14] | BAI Dingxi, GAO Jing, YANG Zhi, WU Chenxi. Development of a Treatment Burden Scale for Elderly Patients with Coexisting Chronic Diseases [J]. Chinese General Practice, 2023, 26(13): 1613-1620. |
[15] | HUANG Pengfei, ZHANG Yunjing, MA Dong, WU Yunyan, ZHAO Yongbo. Relationship between Admission Serum Chloride Level and Postoperative 30-day Mortality in Patients with Acute Stanford Type A Aortic Dissection [J]. Chinese General Practice, 2023, 26(11): 1330-1339. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||